Literature DB >> 11324638

Rituximab: a very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma.

F Bauduer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11324638     DOI: 10.1046/j.1365-2141.2001.02622-3.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Use of rituximab in autoimmune hemolytic anemia associated with non-hodgkin lymphomas.

Authors:  Claudio Fozza; Maurizio Longinotti
Journal:  Adv Hematol       Date:  2011-04-10

Review 2.  B cell depletion in autoimmune disease.

Authors:  Claire Gorman; Maria Leandro; David Isenberg
Journal:  Arthritis Res Ther       Date:  2003-10-02       Impact factor: 5.156

3.  Clinical analysis of 20 patients with non-Hodgkin lymphoma and autoimmune hemolytic anemia: A retrospective study.

Authors:  Ji-Cheng Zhou; Mei-Qing Wu; Zheng-Mian Peng; Wei-Hua Zhao; Zhen-Jie Bai
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.